RGNX   $8.1  -3.11% Market Closed After Close 8.15 0.62%

REGENXBIO Inc.
Total Cash 290.36M
totalCashPerShare 5.875
EBITDA -226.02M
Total Debt 158.72M
quickRatio 3.414
currentRatio 3.528
Total Revenue 89.04M
debtToEquity 45.573
Revenue/Share 1.933
ROA -0.24261
ROE -0.63936
grossProfits
freeCashflow -105.63M
operatingCashflow -191.12M
earningsGrowth
revenueGrowth 0.116
grossMargins -1.98511
ebitdaMargins -2.53834
operatingMargins -2.51343
profitMargins -2.70738
enterpriseValue 309.21M
forwardPE -9.721649
floatShares 40.80M
sharesOutstanding 49.42M
sharesShort 4.99M
sharesShortPriorMonth 6.20M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.90%
Short Ratio help_outline 8.24%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 7.062
Price To Book help_outline 1.34
earningsQuarterlyGrowth
netIncomeToCommon -241.08M
trailingEps -5.24%
forwardEps -0.97%
enterpriseToEbitda -1.37
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.12 3Q 2024
institutionsCount 273
lastUpdated Nov. 7, 2024, 2:02 a.m.